The spread of antimalarial drug resistance: A mathematical model with practical implications for ACT drug policies
Correspondence: (Login to view email address)
- Mahidol - Oxford Tropical Medicine Research Unit, Faculty of Tropical Medicine
- Liverpool School of Topical Medicine
- Mahidol University, Wellcome Unit, Faculty of Tropical Medicine
PDF (526.3 KB)
This manuscript is a preprint. A published version is available at:
10.1186/1475-2875-7-229 (Peer Reviewed) Published in Malaria Journal 7:229.- Document Type:
- Manuscript
- Date:
- Received 24 January 2008 05:15 UTC; Posted 24 January 2008
- Subjects:
- Microbiology, Pharmacology, Bioinformatics
- Abstract:
Most malaria-endemic countries are implementing a change in antimalarial drug policy to artemisinin combination therapy (ACT). The impact of different drug choices and implementation strategies is uncertain. A comprehensive model was constructed incorporating important epidemiological and biological factors and used to illustrate the spread of resistance in low and high transmission settings. The model predicts robustly that in low transmission settings drug resistance spreads faster than in high transmission settings, and that in low transmission areas ACTs slows the spread of drug resistance to a partner drug, especially at high coverage rates. This effect decreases exponentially with increasing delay in deploying the ACT and decreasing rates of coverage. A major obstacle to achieving the benefits of high coverage is the current cost of the drugs. This argues strongly for a global subsidy to make ACTs generally available and affordable in endemic areas.
Discussion
- Votes:
-
1 vote
- Comments:
-
1 comment
- (Login to share with a colleague)
Additional information
- License:
- This document is licensed to the public under the Creative Commons Attribution 3.0 License
- How to cite this document:
-
Pongtavornpinyo, Wirichada, Yeung, Shunmay, Hastings, Ian, Dondorp, Arjen, Day, Nicholas, and White, Nicholas. The spread of antimalarial drug resistance: A mathematical model with practical implications for ACT drug policies. Available from Nature Precedings <http://hdl.handle.net/10101/npre.2008.1539.1> (2008)
- Version info:
-
Other versions of this document in Nature Precedings
None.
Other versions of this document elsewhere on the web
None known.
Jean-Pierre Van geertruyden on 01 August 2008 15:40 UTC
Interesting document but Tables and Supplementary information is lacking to interpret adequately.